First international TNBC conference meeting report

Breast Cancer Res Treat. 2018 Jun;169(3):407-412. doi: 10.1007/s10549-018-4692-3. Epub 2018 Feb 8.


Recently, Georgia State University's Centennial Hall was the premier location for the 2017 International Conference on Triple Negative Breast Cancer (TNBC): Illuminating Actionable Biology, which was held from Sept. 18 to 20, 2017, in Atlanta, USA. The conference featured a stellar line-up of domestic and international speakers and diverse participants including TNBC survivors, luminaries in breast cancer research, medical students and fellows, clinicians, translational researchers, epidemiologists, biostatisticians, bioinformaticians, and representatives from the industry. This report distills the burning questions that spiked the event and summarizes key themes, findings, unique opportunities and future directions that emerged from this confluence of thought leaders.

Keywords: Immunotherapy; Molecular subtypes; Racial disparities; Targeted drugs; Triple negative breast cancer.

Publication types

  • Congress

MeSH terms

  • Animals
  • Biomarkers, Tumor
  • Delivery of Health Care
  • Female
  • Healthcare Disparities
  • Humans
  • Molecular Targeted Therapy
  • Risk Factors
  • Triple Negative Breast Neoplasms / diagnosis*
  • Triple Negative Breast Neoplasms / epidemiology
  • Triple Negative Breast Neoplasms / etiology
  • Triple Negative Breast Neoplasms / therapy*


  • Biomarkers, Tumor